Temodal 2, 5 mg/ ml anvendes konkomitant med fokal strålebehandling (konkomitant fase) efterfulgt af op til 6 serier af temozolomid (TMZ) - monoterapi (monoterapi fase).
Temodal 2.5 mg/ml is administered in combination with focal radiotherapy (concomitant phase) followed by up to 6 cycles of temozolomide (TMZ) monotherapy (monotherapy phase).